Arch Venture Partners, an investment company headquartered in Chicago, IL, announced on April 2, 2020 that it closed two new funds, ARCH Venture Fund X and ARCH Venture Fund X Overage, for a total of $1.46 billion combined to invest in earl... Read More >

Avet Pharmaceuticals (East Brunswick, New Jersey) is voluntarily recalling Tetracycline HCl Capsules USP, 250 mg and 500 mg, 100-count bottles because of low out-of-specification dissolution test results. The recalled product was distribute... Read More >

Amneal Pharmaceuticals, Bridgewater, NJ, announced on April 15, 2020 that it was recalling three lots of Nizatidine Oral Solution, 15 mg/mL (75 mg/5mL), packaged in 480 mL bottles and distributed by Gemini Laboratories, because of potential... Read More >

A new research portal from software developer Nference and Johnson & Johnson's Janssen Pharmaceutica has identified several new expression mechanisms for COVID-19 and the novel SARS-CoV-2 coronavirus that causes the deadly disease. ... Read More >

A public-private consortium in Israel will collect samples and sequence genomes from thousands of COVID-19 patients in an effort to identify protective and risk-bearing genetic factors with the hopes of discovering new diagnostic and treatm... Read More >

The US Food and Drug Administration on Friday granted Emergency Use Authorization to the Rutgers Clinical Genomics Laboratory for a SARS-CoV-2 test originally developed by Thermo Fisher Scientific that is modified for use on additional spec... Read More >

The US Food and Drug Administration on Friday granted Emergency Use Authorization to the Rutgers Clinical Genomics Laboratory for a SARS-CoV-2 test originally developed by Thermo Fisher Scientific that is modified for use on additional spec... Read More >

Prompted in part by the COVID-19 pandemic, the T.H. Chan School of Public Health at Harvard University and the Human Vaccines Project on Tuesday announced a joint effort to accelerate the development of new vaccines, diagnostics, and treatm... Read More >

African genomics research company 54gene said on Tuesday that it has closed a $15 million Series A financing round. The round was led by Adjuvant Capital, a life sciences fund backed by the International Finance Corporation, Novartis, and t... Read More >

A multi-omic analysis of high-grade serous ovarian cancer has uncovered molecular differences between clinical subgroups of the disease. Ovarian cancer is common and aggressive, affecting about 22,500 people in the US each year, according t... Read More >